CAS: 669770-29-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (R)-3-((6-(p-Tolyl)pyridin-3-yl)oxy)quinuclidine REF: IN-DA01K9LXCAS: 669770-29-0 | 98% | To inquire | Mon 02 Dec 24 |
 | AQW-051 REF: 3D-UBB77029CAS: 669770-29-0 | Min. 95% | To inquire | Mon 13 Jan 25 |
 | AQW051 REF: TM-T26646CAS: 669770-29-0 | 99.67% | 36.00 €~1,000.00 € | Tue 21 Jan 25 |
(R)-3-((6-(p-Tolyl)pyridin-3-yl)oxy)quinuclidine
CAS:669770-29-0
Formula:
C19H22N2O
Purity:
98%
Molecular weight:
294.3908
Ref: IN-DA01K9LX
| 5mg | 198.00 € | ||
| 10mg | 335.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
AQW-051
CAS:669770-29-0
AQW-051 is a salt form of nicotinic acid. Nicotinic acid is a medication used to …
Formula:
C19H22N2O
Purity:
Min. 95%
Molecular weight:
294.4 g/mol
Ref: 3D-UBB77029
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
AQW051
CAS:669770-29-0
AQW051 (VQW-765) is an oral α7-nAChR activator for cognitive impairments, used in anxiety disorder studies.
Formula:
C19H22N2O
Purity:
99.67%
Color and Shape:
Solid
Molecular weight:
294.39
Ref: TM-T26646
| 1mg | 36.00 € | ||
| 2mg | 48.00 € | ||
| 5mg | 70.00 € | ||
| 10mg | 104.00 € | ||
| 25mg | 215.00 € | ||
| 50mg | 328.00 € | ||
| 100mg | 461.00 € | ||
| 500mg | 1,000.00 € | ||
| 1mL*10mM (DMSO) | 71.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
